Published in Crit Care Med on February 01, 2012
The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill. Physiol Rev (2015) 1.20
Inflammation-induced acute phase response in skeletal muscle and critical illness myopathy. PLoS One (2014) 0.85
Muscle RING-finger 2 and 3 maintain striated-muscle structure and function. J Cachexia Sarcopenia Muscle (2015) 0.81
The E3 ubiquitin ligase TRIM62 and inflammation-induced skeletal muscle atrophy. Crit Care (2014) 0.79
Slow recovery of the impaired fatigue resistance in postunloading mouse soleus muscle corresponding to decreased mitochondrial function and a compensatory increase in type I slow fibers. Am J Physiol Cell Physiol (2015) 0.76
Muscle mass, strength and functional outcomes in critically ill patients after cardiothoracic surgery: does neuromuscular electrical stimulation help? The Catastim 2 randomized controlled trial. Crit Care (2016) 0.75
Deletion of Nlrp3 protects from inflammation-induced skeletal muscle atrophy. Intensive Care Med Exp (2017) 0.75
Assessment and predictors of physical functioning post-hospital discharge in survivors of critical illness. Ann Intensive Care (2016) 0.75
Imaging opens possibilities both to target and to evaluate nutrition in critical illness. Crit Care (2014) 0.75
Measurement of muscle strength with handheld dynamometer in Intensive Care Unit. Indian J Crit Care Med (2016) 0.75
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PLoS One (2010) 6.38
Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med (2009) 4.98
Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev (2007) 4.50
An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care (2007) 4.14
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
Different assessment tools for intensive care unit delirium: which score to use? Crit Care Med (2010) 2.91
Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome. Crit Care Med (2005) 2.46
Nonexcitable muscle membrane predicts intensive care unit-acquired paresis in mechanically ventilated, sedated patients. Crit Care Med (2009) 2.28
Long-term recovery In critical illness myopathy is complete, contrary to polyneuropathy. Muscle Nerve (2014) 2.21
Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice. Cell Metab (2011) 1.98
Bispectral index-guided sedation with dexmedetomidine in intensive care: a prospective, randomized, double blind, placebo-controlled phase II study. Crit Care Med (2002) 1.94
Dysfunction of dysferlin-deficient hearts. J Mol Med (Berl) (2007) 1.89
The effect of computerized tailored brief advice on at-risk drinking in subcritically injured trauma patients. J Trauma (2006) 1.77
A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One (2012) 1.72
Cereal fiber improves whole-body insulin sensitivity in overweight and obese women. Diabetes Care (2006) 1.67
Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-InterAct case-cohort study. PLoS Med (2012) 1.67
Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21. Diabetes (2009) 1.66
Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations. PLoS Genet (2010) 1.62
Duration of fluid fasting and choice of analgesic are modifiable factors for early postoperative delirium. Eur J Anaesthesiol (2010) 1.59
Dysferlin-deficient muscular dystrophy: gadofluorine M suitability at MR imaging in a mouse model. Radiology (2008) 1.53
Agreement of central venous saturation and mixed venous saturation in cardiac surgery patients. Intensive Care Med (2007) 1.51
Comparison of uncalibrated arterial waveform analysis in cardiac surgery patients with thermodilution cardiac output measurements. Crit Care (2006) 1.51
Predictive ability of the stability and workload index for transfer score to predict unplanned readmissions after ICU discharge. Crit Care Med (2013) 1.50
Changes of adiponectin oligomer composition by moderate weight reduction. Diabetes (2005) 1.50
New strategies to detect alcohol use disorders in the preoperative assessment clinic of a German university hospital. Anesthesiology (2008) 1.50
Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus 'conventional' protective ventilation (6 ml/kg) in severe ARDS: the prospective randomized Xtravent-study. Intensive Care Med (2013) 1.49
A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway. Proc Natl Acad Sci U S A (2004) 1.49
Restoration of cone vision in the CNGA3-/- mouse model of congenital complete lack of cone photoreceptor function. Mol Ther (2010) 1.46
Contemporary fluid management in cardiac anesthesia. J Cardiothorac Vasc Anesth (2010) 1.46
Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy. Am J Hum Genet (2009) 1.44
Fiberoptic transorbital intubation: alternative for tracheotomy in patients after exenteration of the orbit. Anesthesiology (2002) 1.39
Frataxin deficiency in pancreatic islets causes diabetes due to loss of beta cell mass. J Clin Invest (2003) 1.37
Diabetes mellitus type 2 in urban Ghana: characteristics and associated factors. BMC Public Health (2012) 1.33
Protein kinase D1 stimulates MEF2 activity in skeletal muscle and enhances muscle performance. Mol Cell Biol (2008) 1.27
A high normal TSH is associated with the metabolic syndrome. Clin Endocrinol (Oxf) (2010) 1.23
Pulse contour analysis after normothermic cardiopulmonary bypass in cardiac surgery patients. Crit Care (2005) 1.21
Social support during intensive care unit stay might improve mental impairment and consequently health-related quality of life in survivors of severe acute respiratory distress syndrome. Crit Care (2006) 1.21
Fibroblast growth factor 21 mediates specific glucagon actions. Diabetes (2013) 1.20
Epidemiologic analysis of 1,442 children and adolescents registered in the German germ cell tumor protocols. Pediatr Blood Cancer (2004) 1.19
IL6 gene promoter polymorphisms and type 2 diabetes: joint analysis of individual participants' data from 21 studies. Diabetes (2006) 1.18
Tryptophan deprivation induces inhibitory receptors ILT3 and ILT4 on dendritic cells favoring the induction of human CD4+CD25+ Foxp3+ T regulatory cells. J Immunol (2009) 1.17
Evidence for a differential expression of the FcepsilonRIgamma chain in dendritic cells of atopic and nonatopic donors. J Clin Invest (2003) 1.16
Plasma resistin levels and risk of myocardial infarction and ischemic stroke. J Clin Endocrinol Metab (2008) 1.16
Genetic variation in GPR133 is associated with height: genome wide association study in the self-contained population of Sorbs. Hum Mol Genet (2009) 1.16
Evidence that kidney function but not type 2 diabetes determines retinol-binding protein 4 serum levels. Diabetes (2008) 1.16
Histone deacetylase 6 (HDAC6) is an essential modifier of glucocorticoid-induced hepatic gluconeogenesis. Diabetes (2011) 1.15
The polycystic ovary syndrome per se is not associated with increased chronic inflammation. Eur J Endocrinol (2004) 1.15
Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study. Crit Care (2010) 1.14
Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy. Hum Mol Genet (2008) 1.13
Gender differences in the performance of a computerized version of the alcohol use disorders identification test in subcritically injured patients who are admitted to the emergency department. Alcohol Clin Exp Res (2004) 1.12
Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock. J Cachexia Sarcopenia Muscle (2010) 1.11
Statistical methods for comparing comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry results: metabolomic analysis of mouse tissue extracts. J Chromatogr A (2005) 1.10
Reference intervals for insulin-like growth factor-1 (igf-i) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations. J Clin Endocrinol Metab (2014) 1.09
Circulating immune parameters predicting the progression from hospital-acquired pneumonia to septic shock in surgical patients. Crit Care (2005) 1.09
Cognitive Reserve and the Risk of Postoperative Cognitive Dysfunction. Dtsch Arztebl Int (2017) 1.07
A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels. Alcohol Clin Exp Res (2004) 1.07
Clonal tracking of autoaggressive T cells in polymyositis by combining laser microdissection, single-cell PCR, and CDR3-spectratype analysis. Proc Natl Acad Sci U S A (2003) 1.07
KCNJ11 E23K affects diabetes risk and is associated with the disposition index: results of two independent German cohorts. Diabetes Care (2007) 1.06
Contractures and hypertrophic cardiomyopathy in a novel FHL1 mutation. Ann Neurol (2010) 1.06
Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index. J Clin Endocrinol Metab (2008) 1.06
Increased susceptibility to complement attack due to down-regulation of decay-accelerating factor/CD55 in dysferlin-deficient muscular dystrophy. J Immunol (2005) 1.06
Propagation of cortical spreading depolarization in the human cortex after malignant stroke. Neurology (2013) 1.05
Stabilization of hypoxia inducible factor rather than modulation of collagen metabolism improves cardiac function after acute myocardial infarction in rats. Eur J Heart Fail (2006) 1.05
GLP-1-based therapies: the dilemma of uncertainty. Gastroenterology (2011) 1.04
Sex differences in physiological cardiac hypertrophy are associated with exercise-mediated changes in energy substrate availability. Am J Physiol Heart Circ Physiol (2011) 1.04
Polymorphisms within insulin-degrading enzyme (IDE) gene determine insulin metabolism and risk of type 2 diabetes. J Mol Med (Berl) (2009) 1.03
Bispectral index versus COMFORT score to determine the level of sedation in paediatric intensive care unit patients: a prospective study. Crit Care (2004) 1.03
L-FABP T94A is associated with fasting triglycerides and LDL-cholesterol in women. Mol Genet Metab (2007) 1.02
Clinical implications of the EGF receptor/ligand system for tumor progression and survival in gastrointestinal carcinomas: evidence for new therapeutic options. Recent Results Cancer Res (2003) 1.01
Preoperative oral carbohydrate administration to ASA III-IV patients undergoing elective cardiac surgery. Anesth Analg (2006) 1.01
Novel sequence variants in dysferlin-deficient muscular dystrophy leading to mRNA decay and possible C2-domain misfolding. Hum Mutat (2006) 1.00
Relation between retinol, retinol-binding protein 4, transthyretin and carotid intima media thickness. Atherosclerosis (2010) 1.00
Sarcolemmal repair is a slow process and includes EHD2. Traffic (2012) 1.00
Fibroblast growth factor 21 predicts the metabolic syndrome and type 2 diabetes in Caucasians. Diabetes Care (2012) 1.00
Effect of pro-inflammatory and immunoregulatory cytokines on human tenocytes. J Orthop Res (2010) 1.00
Antibiotic-mediated release of tumour necrosis factor alpha and norharman in patients with hospital-acquired pneumonia and septic encephalopathy. Intensive Care Med (2004) 0.99
Acetylsalicylic acid improves lipid-induced insulin resistance in healthy men. J Clin Endocrinol Metab (2005) 0.98
The role of insulin-like growth factor (IGF) binding protein-2 in the insulin-mediated decrease in IGF-I bioactivity. J Clin Endocrinol Metab (2009) 0.98
CD83 localization in a recycling compartment of immature human monocyte-derived dendritic cells. Int Immunol (2005) 0.98
Prone position during ECMO is safe and improves oxygenation. Int J Artif Organs (2013) 0.98
Critical illness myopathy and GLUT4: significance of insulin and muscle contraction. Am J Respir Crit Care Med (2012) 0.98
Dynamics of myosin degradation in intensive care unit-acquired weakness during severe critical illness. Intensive Care Med (2014) 0.97